Xavier Canat
4Patents
2h-index
2Co-inventors
27Inventor score
Filing activity: Dec 15, 1986 → Sep 8, 1989
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4911911A | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein | Emerging Cross-Sectional Technologies | 5 | Expired |
| US4911912A | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5104976A | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a Schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5106956A | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and reduction, and in vivo prolonged-action immunotoxins containing such a glycoprotein | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.